-
7
-
-
33644701805
-
-
Patent No. US6187918, February 13, 2001.
-
Nugent, W. A. Patent No. US6187918, February 13, 2001.
-
-
-
Nugent, W.A.1
-
8
-
-
1942456786
-
-
For a recent review article see: R. Wijtmans, M.K.S. Vink, H.E. Schoemaker, F.L. van Delft, R.H. Blaauw, and F.P.J.T. Rutjes Synthesis 2004 641 662
-
(2004)
Synthesis
, pp. 641-662
-
-
Wijtmans, R.1
Vink, M.K.S.2
Schoemaker, H.E.3
Van Delft, F.L.4
Blaauw, R.H.5
Rutjes, F.P.J.T.6
-
10
-
-
33644691836
-
-
Patent No. WO2005026152, March 03, 2005.
-
Although, (S)-3-(hydroxymethyl)morpholine (S)-6 is cited in the following patents, there is no information on analytical data; (a) Bradbury, R. H.; Hennequin, L. F. A.; Kettle, J. G. Patent No. WO2005026152, March 03, 2005.
-
-
-
Bradbury, R.H.1
Hennequin, L.F.A.2
Kettle, J.G.3
-
11
-
-
33644688396
-
-
Patent No. WO2004094410, November 04, 2004.
-
Heron, N. M.; Pasquet, G. R.; Mortlock, A. A.; Jung, F. H. Patent No. WO2004094410, November 04, 2004.
-
-
-
Heron, N.M.1
Pasquet, G.R.2
Mortlock, A.A.3
Jung, F.H.4
-
12
-
-
33644686395
-
-
Patent No. WO9857954, December 23, 1998.
-
Miyake, H.; Take, K.; Shigenaga, S.; Azami, H.; Sasaki, H.; Eikyu, Y.; Nakai, K.; Ishida, J.; Manabe, T.; Konishi, N.; Terasaka, T. Patent No. WO9857954, December 23, 1998.
-
-
-
Miyake, H.1
Take, K.2
Shigenaga, S.3
Azami, H.4
Sasaki, H.5
Eikyu, Y.6
Nakai, K.7
Ishida, J.8
Manabe, T.9
Konishi, N.10
Terasaka, T.11
-
13
-
-
33644699493
-
-
Patent No. WO9832757, July 30, 1998. Tyger Scientific Inc., NJ, USA, is a commercial vendor of (S)-3-(hydroxymethyl)morpholine (price is $1500/g).
-
Fukuda, Y.; Shimazawa, R.; Oomori, Y.; Terashima, S. Patent No. WO9832757, July 30, 1998. Tyger Scientific Inc., NJ, USA, is a commercial vendor of (S)-3-(hydroxymethyl)morpholine (price is $1500/g).
-
-
-
Fukuda, Y.1
Shimazawa, R.2
Oomori, Y.3
Terashima, S.4
-
14
-
-
0026553308
-
-
During the initial synthesis, when chloroacetyl chloride was used as the coupling agent instead of tert-butyl bromoacetate, (S)-6 was obtained in four steps in 12% overall yield starting from 1 J. Nozulak, J.M. Vigouret, A.L. Jaton, A. Hofmann, A.R. Dravid, H.P. Weber, H.O. Kalkman, and M.D. Walkinshaw J. Med. Chem. 35 1992 480 489
-
(1992)
J. Med. Chem.
, vol.35
, pp. 480-489
-
-
Nozulak, J.1
Vigouret, J.M.2
Jaton, A.L.3
Hofmann, A.4
Dravid, A.R.5
Weber, H.P.6
Kalkman, H.O.7
Walkinshaw, M.D.8
-
21
-
-
0000914701
-
-
L. Sola, K.S. Reddy, A. Vidal-Ferran, A. Moyano, M.A. Pericas, A. Riera, A. Alvarez-Larena, and J.-F. Piniella J. Org. Chem. 63 1998 7078 7082
-
(1998)
J. Org. Chem.
, vol.63
, pp. 7078-7082
-
-
Sola, L.1
Reddy, K.S.2
Vidal-Ferran, A.3
Moyano, A.4
Pericas, M.A.5
Riera, A.6
Alvarez-Larena, A.7
Piniella, J.-F.8
-
22
-
-
33644688607
-
-
(±)3-(Hydroxydiphenylmethyl)morpholine is known as a hydrochloride salt: S.O. Winthrop, and L.G. Humber J. Org. Chem. 26 1960 2834 2836
-
(1960)
J. Org. Chem.
, vol.26
, pp. 2834-2836
-
-
Winthrop, S.O.1
Humber, L.G.2
-
25
-
-
85011163872
-
-
(S)-N-Benzyl-3-(hydroxydiphenylmethyl)morpholine is reported by Ogata et al. in racemic form: M. Ogata, H. Matsumoto, and H. Kano Kogyo Kagaku Zasshi 72 1969 195 196
-
(1969)
Kogyo Kagaku Zasshi
, vol.72
, pp. 195-196
-
-
Ogata, M.1
Matsumoto, H.2
Kano, H.3
-
26
-
-
33644691415
-
-
note
-
If the reaction with (S)-19 and (S)-26 involves the same transition state as with (S)-6 then the expected absolute configuration of the product is (R).
-
-
-
-
37
-
-
0001757279
-
-
S. Vyskocil, S. Jacarz, M. Smrcina, V. Hanus, M. Polasek, and P. Kocovsky J. Org. Chem. 63 1998 7727 7737
-
(1998)
J. Org. Chem.
, vol.63
, pp. 7727-7737
-
-
Vyskocil, S.1
Jacarz, S.2
Smrcina, M.3
Hanus, V.4
Polasek, M.5
Kocovsky, P.6
|